Clinical Trials Arena November 11, 2024
A GlobalData analyst has warned that Trump’s second term could see major changes in US healthcare, and RFK could rock the boat.
An analyst has warned of likely instability in the US’ healthcare systems following the election of Donald Trump as the country’s President, in particular pointing to the possible appointment of anti-vaccine advocate Robert F. Kennedy Jr (RFK) to oversee health within the administration and changes to the Affordable Care Act (ACA).
GlobalData pharmaceuticals analyst Cyrus Fran commented: “During his first term, Trump attempted but failed to repeal ACA but he may consider revisiting it. However, in his 2024 campaign, he stated he would not pursue an ACA repeal in his second term, opting instead to propose an alternative...
Today's Sponsors
Today's Sponsor